Managing Cutaneous Manifestations of Hyperandrogenic Disorders: The Role of Oral Contraceptives

ISSN： 1175-6349

Source： Treatments in Endocrinology, Vol.1, Iss.6, 2002-01, pp. : 373-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral contraceptives and endometriosis

By Roman Horace

Human Reproduction, Vol. 26, Iss. 6, 2011-06 ,pp. : 1600-1601

Oxford University Press

Access to resources Recommend Favorite

Cutaneous Manifestations of Diabetes Mellitus

Medical Principles and Practice, Vol. 15, Iss. 6, 2006-10 ,pp. : 427-430

Karger

Access to resources Recommend Favorite

Are third-generation oral contraceptives safe?

By Rosenberg Lynn

Human Reproduction, Vol. 11, Iss. 4, 1996-04 ,pp. : 687-688

Oxford University Press

Access to resources Recommend Favorite

The future of oral contraceptives: research priorities

By Spitzer Walter O.

Human Reproduction, Vol. 11, Iss. 4, 1996-04 ,pp. : 688-689

Oxford University Press

Access to resources Recommend Favorite

Reply: Oral contraceptives and the endometriosis domino effect

By Vercellini Paolo Crosignani Pier Giorgio Somigliana Edgardo Viganò Paola Frattaruolo Maria Pina Fedele Luigi

Human Reproduction, Vol. 26, Iss. 6, 2011-06 ,pp. : 1601-1602

Oxford University Press

Access to resources Recommend Favorite